Disease |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
clear cell renal cell carcinoma |
microarray, qPCR etc. |
renal clear cell carcinoma tissue |
up-regulated |
N/A |
ENST00000456816, X91348, BC029135, NR_024418 were evaluated by qPCR in sixty-three pairs of RCCC and NT samples. The results demonstrated that ENST00000456816, X91348 were up-regulated and BC029135, NR_024418 were down-regulated in RCCC samples compared with NT samples (p<0.001 for each lncRNAs). |
22879955 |
Lnc2Cancer
|
DiGeorge syndrome |
N/A |
N/A |
N/A |
expression |
The DiGeorge syndrome-associated noncoding RNA, DGCR5, is repressed by REST through a proximal upstream binding site. |
19050060 |
LncRNADisease
|
velocardiofacial syndrome |
N/A |
N/A |
N/A |
N/A |
Association |
20380817 |
LncRNADisease
|
Huntington's disease |
N/A |
N/A |
N/A |
expression |
Interestingly, many of these lncRNAs contain genomic binding sites for the transcriptional repressor REST, a key mediator of transcriptional changes in HD, including the known REST target lncRNA, DGCR5. |
23346095 |
LncRNADisease
|
DiGeorge syndrome |
N/A |
N/A |
N/A |
mutation |
DGCR5 is disrupted by the patient ADU breakpoint. |
8659529 |
LncRNADisease
|
|